| Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions M Esler, G Jennings, G Lambert, I Meredith, M Horne, G Eisenhofer Physiological reviews 70 (4), 963-985, 1990 | 983 | 1990 |
| The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover M Esler, G Jennings, P Korner, I Willett, F Dudley, G Hasking, W Anderson, ... Hypertension 11, 3-20, 1988 | 876 | 1988 |
| Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation MP Schlaich, E Lambert, DM Kaye, Z Krozowski, DJ Campbell, G Lambert, ... Hypertension 43 (2), 169-175, 2004 | 777 | 2004 |
| Effect of sunlight and season on serotonin turnover in the brain GW Lambert, C Reid, DM Kaye, GL Jennings, MD Esler The Lancet 360 (9348), 1840-1842, 2002 | 748 | 2002 |
| Cardiac sympathetic nerve function in congestive heart failure G Eisenhofer, P Friberg, B Rundqvist, AA Quyyumi, G Lambert, DM Kaye, ... Circulation 93 (9), 1667-1676, 1996 | 567 | 1996 |
| Sympathetic activation in chronic renal failure MP Schlaich, F Socratous, S Hennebry, N Eikelis, EA Lambert, ... Journal of the American Society of Nephrology 20 (5), 933-939, 2009 | 552 | 2009 |
| Mechanisms of sympathetic activation in obesity-related hypertension M Esler, N Straznicky, N Eikelis, K Masuo, G Lambert, E Lambert Hypertension 48 (5), 787-796, 2006 | 535 | 2006 |
| Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects M Vaz, G Jennings, A Turner, H Cox, G Lambert, M Esler Circulation 96 (10), 3423-3429, 1997 | 532 | 1997 |
| Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012 | 464 | 2012 |
| Sympathetic nervous system and insulin resistance: from obesity to diabetes M Esler, M Rumantir, G Wiesner, D Kaye, J Hastings, G Lambert American journal of hypertension 14 (S7), 304S-309S, 2001 | 451 | 2001 |
| Benefits for type 2 diabetes of interrupting prolonged sitting with brief bouts of light walking or simple resistance activities PC Dempsey, RN Larsen, P Sethi, JW Sacre, NE Straznicky, ND Cohen, ... Diabetes care 39 (6), 964-972, 2016 | 444 | 2016 |
| Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders G Lambert, M Johansson, H Ågren, P Friberg Archives of general psychiatry 57 (8), 787-793, 2000 | 439 | 2000 |
| Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension D Hering, EA Lambert, P Marusic, AS Walton, H Krum, GW Lambert, ... Hypertension 61 (2), 457-464, 2013 | 412 | 2013 |
| Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications GW Lambert, NE Straznicky, EA Lambert, JB Dixon, MP Schlaich Pharmacology & therapeutics 126 (2), 159-172, 2010 | 411 | 2010 |
| Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage S Naredi, G Lambert, E Eden, S Zall, M Runnerstam, B Rydenhag, ... Stroke 31 (4), 901-906, 2000 | 391 | 2000 |
| Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial JB Dixon, LM Schachter, PE O’Brien, K Jones, M Grima, G Lambert, ... Jama 308 (11), 1142-1149, 2012 | 365 | 2012 |
| Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure DM Kaye, GW Lambert, J Lefkovits, M Morris, G Jennings, MD Esler Journal of the American College of Cardiology 23 (3), 570-578, 1994 | 348 | 1994 |
| Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? DA Barton, T Dawood, EA Lambert, MD Esler, D Haikerwal, C Brenchley, ... Journal of hypertension 25 (10), 2117-2124, 2007 | 339 | 2007 |
| Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure M Petersson, P Friberg, G Eisenhofer, G Lambert, B Rundqvist European heart journal 26 (9), 906-913, 2005 | 303 | 2005 |
| Mechanism of elevated plasma noradrenaline in the course of essential hypertension M Esler, G Jennings, B Biviano, G Lambert, G Hasking Journal of cardiovascular pharmacology 8, S39-S43, 1986 | 296 | 1986 |
Murray EslerSenior Director Baker IDI Heart and Diabetes Institute在 bakeridi.edu.au 的电子邮件经过验证
